Brief: Oncoarendi Therapeutics Gets Recommended For Subsidy Of About 37 Mln Zlotys
29/11/2021 13:44
Nov 29 (Reuters) - Oncoarendi Therapeutics SA OAT.WA :
* GETS RECOMMENDED FOR ESTIMATED SUBSIDY OF 37 MILLION
ZLOTYS FROM
POLAND'S ABM FOR PROJECT
* SUBSIDY IS FOR „DISCOVERY AND DEVELOPMENT OF NOVEL
ANTIVIRAL
DRUGS DESTABILIZING RNA OF CORONAVIRUSES" PROJECT
Source text for Eikon: ID:nEMBBz1na
Further company coverage: OAT.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Molecure SA
See all newsBrief: Molecure Q1 Net Loss 4.1 Mln Zlotys
Brief: Molecure Says Its In-Consortium Project Selected For Funding By Medical Research Agency
Brief: Molecure To Sell 4.12 Mln Series K Shares and 2.0 Mln Existing Shares At 5 Zlotys/Shr
Brief: Molecure Starts ABB For Up to 4.12 Mln New Series K Shares And Up To 2.0 Mln Existing Shares
Brief: Molecure Signs Conditional Investment Agreement With MS Galleon And Szumowski Investments